# Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design

> **NCT01945359** · — · COMPLETED · sponsor: **Rocky Mountain MS Research Group, LLC** · enrollment: 30 (actual)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01945359
- **Lead sponsor:** Rocky Mountain MS Research Group, LLC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-09
- **Final completion:** 2015-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01945359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01945359, "Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01945359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*